Loading chat...

NY A06988

Bill

Status

Introduced

5/9/2023

Primary Sponsor

Jonathan Jacobson

Click for details

Origin

Assembly

2023-2024 General Assembly

AI Summary

  • Pharmacists may substitute a brand name epinephrine auto-injector with an alternate auto-injector containing identical active ingredients, dosage form, and strength, even if not on the official list of interchangeable products.

  • Substitution is permitted only when the prescriber has not marked the prescription "dispense as written."

  • The alternate epinephrine auto-injector must have a lower unit cost to the patient than the brand name product.

  • Pharmacists must inform the patient of the alternate option and obtain written consent before dispensing the substitute.

  • Pharmacists must counsel the patient on proper usage and operating features of the alternate epinephrine auto-injector.

Legislative Description

Relates to the substitution of brand name epinephrine auto-injectors with alternate epinephrine auto-injectors in certain cases.

Last Action

referred to higher education

1/3/2024

Committee Referrals

Higher Education5/9/2023

Full Bill Text

No bill text available